FindTrial
Sign In

Clariscan 0

DRUG3 trials

Sponsors

Biogen Idec Research Limited, Region Skane, Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer

Conditions

Chronic coronary syndromeCoronary artery chronic total occlusionRelapsing Forms of Multiple Sclerosis

Phase 2

A 2-Part, Multicenter, Randomized, Blinded, Active-Controlled Phase 2 Study to Sequentially Evaluate the Safety and Efficacy of BIIB091 Monotherapy and BIIB091 Combination Therapy With Diroximel Fumarate in Participants With Relapsing Forms of Multiple Sclerosis
Active, not recruitingCTIS2022-502552-31-00
Biogen Idec Research LimitedRelapsing Forms of Multiple Sclerosis
Start: 2023-10-03Target: 225Updated: 2025-07-21

Phase 4

HYPER-trial Hyperemic mYocardial Perfusion by adEnosine at diffeRent doses
RecruitingCTIS2023-505248-20-00
Region SkaneChronic coronary syndrome
Start: 2024-10-14Target: 180Updated: 2024-03-05
Evaluation of patients with total coronary occlusions with multimodality image.
Not yet recruitingCTIS2024-519979-26-00
Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I SunyerCoronary artery chronic total occlusion
Target: 78Updated: 2025-01-10